BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Sofetabart mipitecan readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Sofetabart mipitecan\, from ClinicalTrial
 s.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07213804-2607@assetmemo.bio
DTSTAMP:20261121T010440Z
DTSTART;VALUE=DATE:20281130
DTEND;VALUE=DATE:20281201
SUMMARY:Sofetabart mipitecan: Phase 3 readout est. (NCT07213804)
DESCRIPTION:Sofetabart mipitecan\, phase 3\, Ovarian Cancer.\nStudy: A Thre
 e-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum
 -Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer\
 nEstimated primary completion: November 2028. This is a ClinicalTrials.gov
  estimate\, not a confirmed readout date\, and it can move.\nDrug page: ht
 tps://assetmemo.bio/drug/sofetabart-mipitecan#upcoming-events\nRegistry re
 cord: https://clinicaltrials.gov/study/NCT07213804
URL:https://assetmemo.bio/drug/sofetabart-mipitecan#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06400472-2607@assetmemo.bio
DTSTAMP:20261121T010440Z
DTSTART;VALUE=DATE:20290630
DTEND;VALUE=DATE:20290701
SUMMARY:Sofetabart mipitecan: Phase 1 readout est. (NCT06400472)
DESCRIPTION:Sofetabart mipitecan\, phase 1\, Non-Small Cell Lung Cancer.\nS
 tudy: A Study of Sofe-M in Participants With Selected Advanced Solid Tumor
 s\nEstimated primary completion: June 2029. This is a ClinicalTrials.gov e
 stimate\, not a confirmed readout date\, and it can move.\nDrug page: http
 s://assetmemo.bio/drug/sofetabart-mipitecan#upcoming-events\nRegistry reco
 rd: https://clinicaltrials.gov/study/NCT06400472
URL:https://assetmemo.bio/drug/sofetabart-mipitecan#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07928258-2607@assetmemo.bio
DTSTAMP:20261121T010440Z
DTSTART;VALUE=DATE:20320331
DTEND;VALUE=DATE:20320401
SUMMARY:Sofetabart mipitecan: Phase 1 readout est. (NCT07928258)
DESCRIPTION:Sofetabart mipitecan\, phase 1\, Non-Small Cell Lung Cancer.\nS
 tudy: A Study of LY4336619 in Adult Participants With Advanced Solid Tumor
 s\nEstimated primary completion: March 2032. This is a ClinicalTrials.gov 
 estimate\, not a confirmed readout date\, and it can move.\nDrug page: htt
 ps://assetmemo.bio/drug/sofetabart-mipitecan#upcoming-events\nRegistry rec
 ord: https://clinicaltrials.gov/study/NCT07928258
URL:https://assetmemo.bio/drug/sofetabart-mipitecan#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
